DK1525215T3 - Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner - Google Patents
Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormonerInfo
- Publication number
- DK1525215T3 DK1525215T3 DK03784154T DK03784154T DK1525215T3 DK 1525215 T3 DK1525215 T3 DK 1525215T3 DK 03784154 T DK03784154 T DK 03784154T DK 03784154 T DK03784154 T DK 03784154T DK 1525215 T3 DK1525215 T3 DK 1525215T3
- Authority
- DK
- Denmark
- Prior art keywords
- replacement therapy
- modulators
- women
- hormone replacement
- progesterone receptor
- Prior art date
Links
- 230000035558 fertility Effects 0.000 title abstract 2
- 238000002657 hormone replacement therapy Methods 0.000 title abstract 2
- 230000002054 antogonadotrophic effect Effects 0.000 title 1
- 102000003998 progesterone receptors Human genes 0.000 title 1
- 108090000468 progesterone receptors Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40006502P | 2002-08-02 | 2002-08-02 | |
| DE10236405A DE10236405A1 (de) | 2002-08-02 | 2002-08-02 | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1525215T3 true DK1525215T3 (da) | 2007-01-15 |
Family
ID=31716602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03784154T DK1525215T3 (da) | 2002-08-02 | 2003-08-01 | Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1525215B1 (da) |
| JP (1) | JP2005539016A (da) |
| AT (1) | ATE338763T1 (da) |
| AU (1) | AU2003255355A1 (da) |
| DE (1) | DE50304970D1 (da) |
| DK (1) | DK1525215T3 (da) |
| ES (1) | ES2273061T3 (da) |
| WO (1) | WO2004014935A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20011762A1 (it) | 2001-08-10 | 2003-02-10 | Cosmo Spa | Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione |
| DE102006018869A1 (de) * | 2006-04-13 | 2007-10-18 | Bayer Schering Pharma Ag | 17alpha-substituierte 4-(3-Oxoestra-4,9-dien-11beta-yl)-benzoesäure, deren Derivate und Verfahren zu ihrer Herstellung |
| BRPI0702900A2 (pt) * | 2006-06-28 | 2011-03-15 | Teva Pharma | formas cristalinas da atorvastatina |
| US7981927B2 (en) | 2007-03-07 | 2011-07-19 | Janssen Pharmaceutica N.V. | Steroids derivatives as selective progesterone receptor modulators |
| ITMI20071616A1 (it) | 2007-08-03 | 2009-02-04 | Cosmo Spa | Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati. |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| EP2348318A1 (en) * | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| EP3569697B8 (en) | 2014-06-17 | 2022-04-27 | Asherman Therapy, S.L. | Stem cell therapy in endometrial pathologies |
| EP3108879A1 (en) | 2015-06-25 | 2016-12-28 | Cassiopea S.p.A. | High concentration formulation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3504421A1 (de) * | 1985-02-07 | 1986-08-07 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19745085A1 (de) * | 1997-10-11 | 1999-04-15 | Jenapharm Gmbh | 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
| YU13902A (sh) * | 1999-08-31 | 2006-01-16 | Schering Ag. | Mezoprogestini (progesteron receptor modulatori) kao komponente kontraceptivnih sredstava za žene |
| EE200200102A (et) * | 1999-08-31 | 2003-04-15 | Jenapharm Gmbh & Co. Kg | Mesoprogestiinid (progesterooniretseptori modulaatorid) hormoonasendusravi (HAR) kompositsioonide komponendina |
| MEP13808A (en) * | 1999-08-31 | 2010-06-10 | Bayer Schering Pharma Ag | Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders |
| DE19961219A1 (de) * | 1999-12-15 | 2001-07-19 | Jenapharm Gmbh | 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
-
2003
- 2003-08-01 DE DE50304970T patent/DE50304970D1/de not_active Expired - Lifetime
- 2003-08-01 JP JP2004526857A patent/JP2005539016A/ja active Pending
- 2003-08-01 AU AU2003255355A patent/AU2003255355A1/en not_active Abandoned
- 2003-08-01 EP EP03784154A patent/EP1525215B1/de not_active Expired - Lifetime
- 2003-08-01 AT AT03784154T patent/ATE338763T1/de not_active IP Right Cessation
- 2003-08-01 WO PCT/EP2003/008572 patent/WO2004014935A1/de active IP Right Grant
- 2003-08-01 ES ES03784154T patent/ES2273061T3/es not_active Expired - Lifetime
- 2003-08-01 DK DK03784154T patent/DK1525215T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004014935A1 (de) | 2004-02-19 |
| ATE338763T1 (de) | 2006-09-15 |
| EP1525215A1 (de) | 2005-04-27 |
| EP1525215B1 (de) | 2006-09-06 |
| AU2003255355A1 (en) | 2004-02-25 |
| JP2005539016A (ja) | 2005-12-22 |
| DE50304970D1 (de) | 2006-10-19 |
| ES2273061T3 (es) | 2007-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1525215T3 (da) | Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner | |
| MY137053A (en) | Pyrimidine derivatives and their use as cb2 modulators | |
| TR199901174T2 (xx) | Yeni heterosiklilmetil-ikameli pirazol t�revleri. | |
| GB0222495D0 (en) | Compounds | |
| NO20061736L (no) | Krystallform av epotilon B | |
| YU40701A (sh) | Piperidini kao modulatori ccr5 | |
| NO20031266D0 (no) | Kondenserte heterocykliske suksinimid-forbindelser og analoger derav, modulatorer for nukle¶r hormonreseptorfunksjon | |
| NO20003534D0 (no) | Progesteronreseptor-modulatorforbindelser, farmasøytiske sammensetninger inneholdende disse og anvendelsen av forbindelsene | |
| IL187328A (en) | N-methyl-2-fluoro-{4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]}benzamide, pharmaceutical compositions comprising the same and uses thereof in the manufacture of medicaments | |
| ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
| MX2007004862A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias. | |
| GEP20074197B (en) | 5ht2c receptor modulators | |
| NO305657B1 (no) | 4-substituerte piperidinderivater og farmas°ytisk preparat derav | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| DE60039878D1 (de) | XENON ALS NMDA-ANTOGONIST zur Neuroprotektion | |
| DK1063995T3 (da) | Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator | |
| DE60018213D1 (de) | Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons | |
| DK0823903T3 (da) | Heterocykliske biarylforbindelser, farmaceutiske præparater og kosmetiske sammensætninger, der indeholder dem, og anvendelser | |
| AU2001234273A1 (en) | Thiazolopyrimidines and their use as modulators of chemokine receptor activity | |
| DE60221537D1 (de) | Pteridinon-derivate als modulatoren der chemokinrezeptor-aktivität | |
| BR0008437A (pt) | Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos | |
| BR0113165A (pt) | Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados | |
| NO20080441L (no) | Benzofuranonderivater som ikke-steroide progesteronreseptormodulatorer | |
| DK1196442T3 (da) | VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser | |
| DE59809283D1 (de) | Inhibitoren für den urokinaserezeptor |